Let me tell you why we're going to win. We're here because we believe in heart, that's what it's going to take to win,” ...

Sanofi is buying U.K. biotechnology company Vicebio for up to $1.6 billion in a deal that seeks to strengthen the French drugmaker's portfolio of respiratory vaccines and leave pipeline setbacks ...